Proscar Patent Expiration

Proscar is a drug owned by Organon Llc A Sub Of Organon And Co. It is protected by 2 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Oct 23, 2018. Details of Proscar's patents and their expiration are given in the table below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5942519 Prevention of precipitated acute urinary retention
Oct, 2018

(5 years ago)

Expired
US5886184 Finasteride processes
Nov, 2012

(11 years ago)

Expired

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

US patents provide insights into the exclusivity only within the United States, but Proscar is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Proscar's family patents as well as insights into ongoing legal events on those patents.

Proscar's Family Patents


Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List


Generic Launch

Generic Release Date:

Proscar's generic launch date based on the expiry of its last outstanding patent is estimated to be Oct 23, 2018 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Proscar Generics:

Finasteride is the generic name for the brand Proscar. 17 different companies have already filed for the generic of Proscar, with Hetero Labs Ltd Iii having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Proscar's generic

How can I launch a generic of Proscar before its drug patent expiration? :

You can seek FDA approval to launch a generic drug before the expiration of Proscar's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the Proscar's sponsor is invalid, unenforceable, or will not be infringed by your generic product.

Given below are the details of the already filed Para IV certificates on Proscar -

Strength Submission Date ANDA(s) Filed First applicant approval Last patent expiry 180 day status
5 mg

Alternative Brands for Proscar

Proscar which is used for treating acute urinary retention in patients., has several other brand drugs using the same active ingredient (Finasteride). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.

Drug Owner Drug Name
Organon
Propecia


Apart from brand drugs containing the same ingredient, some generics have also been filed for Finasteride, Proscar's active ingredient. Check the complete list of approved generic manufacturers for Proscar





About Proscar

Proscar is a drug owned by Organon Llc A Sub Of Organon And Co. It is used for treating acute urinary retention in patients. Proscar uses Finasteride as an active ingredient. Proscar was launched by Organon in 1992.

Approval Date:

Proscar was approved by FDA for market use on 19 June, 1992.

Active Ingredient:

Proscar uses Finasteride as the active ingredient. Check out other Drugs and Companies using Finasteride ingredient

Treatment:

Proscar is used for treating acute urinary retention in patients.

Dosage:

Proscar is available in tablet form for oral use. Given below is detailed information on Dosage -

Strength Dosage Form Availability Application Pathway
5MG TABLET Prescription ORAL